Here's Why Artisan Mid Cap Fund Decided to Exit Illumina (ILMN)
Artisan Partners, an investment management company, released its 'Artisan Mid Cap Fund' first quarter 2025 investor letter. A copy of the letter can be downloaded here. In the first quarter, the fund's Investor Class fund ARTMX returned -7.40%, Advisor Class fund APDMX posted a return of -7.37%, and Institutional Class fund APHMX returned -7.35%, compared to a -7.12% return for the Russell Midcap Growth Index. US equities achieved solid Q4 gains, concluding a strong year. After a period of strong growth stock performance in 2023 and 2024, value stocks gained the lead in Q1 2025. In a risk-averse environment, investors shifted towards lower-volatility equities, especially in the utilities and consumer staples sectors, alongside those with higher dividend yields. In addition, please check the fund's top five holdings to know its best picks in 2025.
In its first-quarter 2025 investor letter, Artisan Mid Cap Fund highlighted stocks such as Illumina, Inc. (NASDAQ:ILMN). Illumina, Inc. (NASDAQ:ILMN) is a leading supplier of sequencing- and array-based solutions for genetic and genomic analysis. The one-month return of Illumina, Inc. (NASDAQ:ILMN) was 11.19%, and its shares lost 28.70% of their value over the last 52 weeks. On May 5, 2025, Illumina, Inc. (NASDAQ:ILMN) stock closed at $78.17 per share with a market capitalization of $12.371 billion.
Artisan Mid Cap Fund stated the following regarding Illumina, Inc. (NASDAQ:ILMN) in its Q1 2025 investor letter:
"We ended our investment campaigns inIllumina, Inc. (NASDAQ:ILMN), Best Buy and Datadog during the quarter. Illumina is a leading provider of next generation sequencing instruments for genetic testing. Genome sequencing has become more mainstream as costs have fallen, expanding within academic research and into high-value clinical diagnostic testing applications. However, rising concerns about funding cuts to the National Institute of Health and news that China will restrict Illumina's business have overwhelmed the longer term thesis, leading us to exit the position."
Illumina, Inc. (ILMN): Among Recent Activist Investor Campaigns
A research facility with medical professionals surrounded by diagnostic equipment.
Illumina, Inc. (NASDAQ:ILMN) is not on our list of 30 Most Popular Stocks Among Hedge Funds. As per our database, 61 hedge fund portfolios held Illumina, Inc. (NASDAQ:ILMN) at the end of the fourth quarter compared to 54 in the third quarter. Illumina, Inc.'s (NASDAQ:ILMN) fourth-quarter revenue reached $1.1 billion, surpassing expectations. While we acknowledge the potential of Illumina, Inc. (NASDAQ:ILMN) as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns, and doing so within a shorter timeframe. If you are looking for an AI stock that is as promising as NVIDIA but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Jim Cramer on EHang (EH): 'I'm Not Going to Really Want to Do a Lot of China Right Now'
We recently published a list of . In this article, we are going to take a look at where EHang Holdings Limited (NASDAQ:EH) stands against other stocks that Jim Cramer discusses. A caller asked for Cramer's opinion on EHang Holdings Limited (NASDAQ:EH), and he said: 'You know, I'm not going to really want to do a lot of China right now. I think that the President and China, just don't feel that, I just don't, I'm not getting that vibe, you know what I mean?' EHang (NASDAQ:EH) develops and sells autonomous aerial vehicles and related systems for use in passenger transport, logistics, urban management, and aerial media. The company offers aircraft models, flight control technology, operational software, vertiports, and charging infrastructure for electric vertical takeoff and landing operations. A modern commercial jet airliner decorated with the company logo in flight against a clear blue sky. On May 27, BofA reduced the price target on EHang (NASDAQ:EH) from $26 to $24 and maintained a Buy rating after the company missed expectations in the first quarter due to weaker sales. Taking the first-quarter performance into account, the firm lowered its volume sales projections for 2025 and 2026 by 7% and 8%, and revised its non-GAAP net profit estimates for those years down by 63% and 12%, respectively. Overall, EH ranks 11th on our list of stocks that Jim Cramer discusses. While we acknowledge the potential of EH as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock. READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Insider
2 hours ago
- Business Insider
The Week That Was, The Week Ahead: Macro & Markets, June 8, 2025
Everything to Know about Macro and Markets Stocks clocked in large weekly gains, returning to positive territory year-to-date. The Dow Jones Industrial Average (DJIA) rose by 1.17%, the S&P 500 (SPX) increased by 1.50%, and the tech-heavy Nasdaq-100 (NDX) gained 1.97% for the week. The S&P 500 finished more than 20% above April's low, reclaiming the 6,000 mark first reached in February, although it remained about 2% shy of its record high. Confident Investing Starts Here: Macro Steers the Markets The week began on a positive note, losing some steam in the second half. The weakness in PMI reports – with the manufacturing activity contracting for a third month in a row and services activity shrinking for the first time in 11 months – infused some gloom. However, Friday saw stocks find their footing again on solid job gains, which allayed fears about an imminent economic downturn. U.S. jobs growth stayed strong in May, climbing 139,000 with unemployment unchanged at 4.2%. Although the March and April reports were revised downward, May's report reassured investors, as it reflected a very gradual cooling of the labor market. Still, diving into the job report's details, a stronger-than-expected wage growth continues to put a floor under inflation. This supports the Federal Reserve's 'wait and see' stance, despite President Trump's demands for a cut. According to the CME FedWatch Tool, the chances of a June cut are nil, and July's rate decrease looks increasingly improbable. Prices in interest rate futures markets imply that investors expect two quarter-point rate cuts by year-end, with the first cut not expected until September. Wrapping Up the Season Despite tariff headwinds and macro volatility, S&P 500 companies delivered solid results last quarter. Index members reported 12.9% year-over-year earnings growth – the second straight double-digit increase. 78% of firms – above the five-year average – exceeded EPS estimates. However, the number of companies issuing negative EPS guidance (68) was also above the average. In Q1, the Healthcare sector reported the highest earnings growth, 43%, leaving the Magnificent Seven cohort's 27.7% increase in the dust. In fact, Mag 7's earnings growth rate was below the average (32.1%) of the previous three quarters. Still, three members of the Magnificent bunch – Alphabet (GOOGL), Amazon (AMZN), and Nvidia (NVDA) – are among the top five contributors to earnings growth for the S&P 500 for the first quarter. Interestingly, Bristol Myers Squibb (BMY) and Gilead Sciences (GILD) were the other top contributors. Stocks That Made the News ▣ Tesla (TSLA) lost nearly 15% over the week following the ugly social media spat between Elon Musk and President Donald Trump. The feud flared up over the impending budget bill, with Musk calling it 'disgusting', and followed by Trump's threat to take away billions of dollars in government subsidies and contracts awarded to Musk's businesses. Although shares rebounded on Friday as Musk and Trump moved to cool tensions, the spat cost Tesla over $150 billion loss in market cap. ▣ Broadcom (AVGO) fell on Friday, wiping out its weekly gain, after the chip giant only narrowly surpassed analyst revenue and expectations. In addition, its current quarter revenue guidance was also just above consensus. Solid, but not a blowout quarter and outlook, weighed on shares that recently hit all-time highs. Still, the company delivered on the AI narrative, reporting surging demand and upping AI networking revenue guidance. ▣ Microsoft (MSFT) continued its climb, hitting a fresh record on Friday as analysts raised price targets on acceleration in Azure and AI-related revenue growth. According to Goldman Sachs, Microsoft's cloud revenue could more than double by 2029. The tech leader's market cap has reached $3.5 trillion, surpassing that of Nvidia (NVDA) and making MSFT the largest company in the world. ▣ Lululemon (LULU) shares dove by 20% on Friday, capping large weekly losses, despite earnings beat. The apparel retailer cut guidance on macroeconomic uncertainty and the impact of tariffs that might force LULU to increase prices. ▣ DocuSign (DOCU) was another notable decliner, sinking nearly 19% post earnings. The company reported a strong financial performance, but a miss on billings raised investor fears about future growth. The Q1 2025 earnings season is practically over, but several notable earnings releases are still scheduled for the next few days. These include Casey's General (CASY), Oracle (ORCL), Chewy (CHWY), and Adobe (ADBE).
Yahoo
2 hours ago
- Yahoo
Why Quantum Computing Inc. (QUBT) Soared On Friday
We recently published a list of . In this article, we are going to take a look at where Quantum Computing Inc. (NASDAQ:QUBT) stands against other Friday's best-performing stocks. Quantum Computing surged by 15.81 percent on Friday to end at $13.70 apiece as investors cheered the company's upgraded rating from an investment firm. In its market note, Ascendiant Capital Markets maintained its 'buy' recommendation on Quantum Computing Inc.'s (NASDAQ:QUBT) stock, while raising its price target to $22 from $14 previously. A data analyst pouring over a chart, the intricacies of its lines being revealed. The new price target represented a 60.6 percent upside from the company's latest closing price. In the first quarter of the year, Quantum Computing Inc. (NASDAQ:QUBT) swung to a net income attributable to shareholders of $16.98 million from a $6.4 million net loss in the same period last year, primarily driven by a $23.6 million non-cash gain on the mark-to-market valuation of the company's warrant liability as a result of its merger with QPhoton in June 2022. Revenues, on the other hand, rose by 44 percent to $39,000 from $27,000 in the same period last year. Overall, QUBTranks 3rd on our list of Friday's best-performing stocks. While we acknowledge the potential of QUBT as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock. READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires. Disclosure: None. This article is originally published at Insider Monkey.
